Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04538781 · ClinicalTrials.gov registry record

AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry

A clinical trial of Atrial Fibrillation, sponsored by Cardiva Medical.

Completed
Registry status
497
Enrollment target
4
Study locations

NCT04538781 is a study of Atrial Fibrillation that has completed, run by Cardiva Medical. The registered enrollment target is 497 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (83% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04538781, a study of Atrial Fibrillation, has completed, sponsored by Cardiva Medical.

COMPLETED
Registry status
497 participants
Enrollment target
4
Study locations

Study Summary

A multi-center, retrospective, single arm post market registry to evaluate procedural outcomes data using the Cardiva VASCADE MVP Venous Vascular Closure System (VVCS) for the management of the femoral venotomy after catheter-based atrial fibrillation interventions with or without another arrythmia performed via 6-12F procedural sheaths with single or multiple access sites per limb for patients who are discharged the same day.

Conditions Studied

Interventions

  • DEVICE VASCADE MVP VVCS

Study Locations (4)

California

  • Coastal Cardiology - San Luis Obispo

District of Columbia

  • MedStar Washington - Washington D.C.

Massachusetts

  • Lahey Clinic - Burlington

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 497 participants
Start Date 2020-10-09
Est. Completion 2021-02-08

Sponsor

Cardiva Medical

5 total trials

What the Registry Record Tells You About NCT04538781

The ClinicalTrials.gov registry entry for NCT04538781 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 497 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (83% lower). The listed sponsor is Cardiva Medical, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which VASCADE MVP VVCS is the first listed.

NCT04538781 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, District of Columbia, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04538781 about?

NCT04538781 is a clinical study titled "AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry". A multi-center, retrospective, single arm post market registry to evaluate procedural outcomes data using the Cardiva VASCADE MVP Venous Vascular Closure System (VVCS) for the management of the femoral venotomy after catheter-based atrial fibrillation interventions with or without another arrythmia ...

What is the current status of trial NCT04538781?

This trial is currently completed. The enrollment target is 497 participants. The study started on 2020-10-09. Estimated completion is 2021-02-08.

What conditions does trial NCT04538781 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT04538781?

The interventions under investigation include: VASCADE MVP VVCS (DEVICE).

Who is sponsoring clinical trial NCT04538781?

This trial is sponsored by Cardiva Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04538781 being conducted?

This trial has 4 study locations across California, District of Columbia, Massachusetts, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.